Leading scientists to provide evidence on implications of Brexit for UK science
The House of Lords Science and Technology Committee will continue its investigation into the implications of Brexit on UK science and have the opportunity to question leading scientists on Tuesday 13 September.
The Committee has previously examined the immediate consequences of Brexit and what the Government needs to do to protect the interests of UK science as it negotiates its exit from the EU.
In this session, the Committee will further assess the opportunities and threats that UK science is now faced with as a result of the referendum and will cover issues such as the UK's future access to EU research funding and what the potential loss of this means to businesses and universities. It will also explore what potential there is to collaborate with nations outside of the EU and the visa requirements for EU students who wish to study in the UK.
The witnesses to be questioned on these areas are:
10.20am - Professor Sir David Greenaway, Chair of the Russell Group and Vice-Chancellor of University of Nottingham; Professor David Phoenix, Chair of MillionPlus and Vice Chancellor of London South Bank University; Dr Patrick Vallance, President Pharmaceuticals R&D, GlaxoSmithKline (GSK).
11.20am - Professor John Womersley, Chief Executive of the Science and Technology Facilities Council (STFC) and Chair of the European Strategy Forum on Research Infrastructures (ESFRI); Phil Smith, UK & Ireland Chief Executive of Cisco and Chairman of Innovate UK; Professor Dame Julia Slingo, Chief Scientist of the Met Office and member of the High Level Group of Scientific Advisors of the European Commission Scientific Advice Mechanism.
The evidence sessions will start at 10:20am on Tuesday 13 September. They will be held in Committee Room 4A of the House of Lords.
